Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keishibukuryogan for uterine subinvolution after childbirth
jRCT1091220407Completed
- Sponsor
- Shingo Ukita
- Start
- Jan 2019
- Countries
- 1
01
Overview
Randomised, double-blind trial in subinvolution of the uterus comparing Keishibukuryogan with Methylergometrine + placebo (2 arms). Primary endpoint: Existence of subinvolution. Started Jan 2019; status: completed.
02
Drugs
guizhi fuling wan
03
Conditions
subinvolution of the uterus
Beyond the preview
Go deeper on jRCT1091220407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220407.